Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
language:"English"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=language%3A%22English%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=language%3A%22English%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=language%3A%22English%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
PubPharm (23.080)
1
A Phase 1/2 Study on the effects of the LOXO-292 (study drug) in Pediatric Patients with Advanced Solid or Primary Central Nervous System Tumors : A Phase 1/2 Study of the Oral RET Inhibitor LOXO-292 in Pediatric Patients with Advanced RET-Altered Solid or Primary Central Nervous System Tumors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A dose escalation trial to assess the safety and tolerability of multiple doses of the CAN04 antibody, in patients with solid malignant tumors. : An open label, dose escalation followed by dose expansion, safety and tolerability trial of CAN04, a fully humanized monoclonal antibody against IL1RAP, in subjects with solid malignant tumors - CANFOUR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Study of ALRN-6924, for the Prevention of Topotecan-induced Myelosuppression During Treatment for Small Cell Lung Cancer : A Phase 1b/2 Study of the Dual MDMX/MDM2 Inhibitor, ALRN-6924, for the Prevention of Topotecan-induced Myelosuppression During Treatment for Small Cell Lung Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
An Open-label, Multiple-site, Phase I/II Dose Cohort Trial of [6R] 5,10-Methylene Tetrahydrofolate (Modufolin®) in Combination with a Fixed Dose of 5-Fluorouracil (5-FU) alone or together with a Fixed Dose of Oxaliplatin or Irinotecan in Patients with Stage IV Colorectal Cancer : An Open-label, Multiple-site, Phase I/II Dose Cohort Trial of [6R] 5,10-Methylene Tetrahydrofolate (Modufolin®) in Combination with a Fixed Dose of 5-Fluorouracil (5-FU) alone or together with a Fixed Dose of Oxaliplatin or Irinotecan in Patients with Stage IV Colorectal Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Phase I/II clinical study of IMA970A plus CV8102 and Cyclophosphamide for patients with liver cancer : A phase I/II trial of IMA970A plus CV8102 following a single pre-vaccination infusion of cyclophosphamide in patients with very early, early and intermediate stage of hepatocellular carcinoma after any standard treatments
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Long term continuous infusion ch14.18/CHO plus s.c. aldesleukin (IL-2) randomised : A PHASE I/II DOSE SCHEDULE FINDING STUDYFOR CH14.18/CHO CONTINUOUS INFUSION COMBINED WITH SUBCUTANEOUS ALDESLEUKIN (IL-2)IN PATIENTS WITH PRIMARY REFRACTORY OR RELAPSING NEUROBLASTOMA - Long term continuous infusion ch14.18/CHO
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A study to assess the safety and tolerability of combining G1T28 with etoposide and carboplatin therapy and to evaluate the effect of G1T28 on blood cell production affected by chemotherapy. : Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC) Receiving Etoposide and Carboplatin Chemotherapy - G1T28 safety and pharmacokinetic study in patients receiving etoposide and carboplatin
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A study to evaluate the safety, tolerability and efficacy of AUP1602-C product for diabetic foot ulcers : A Phase 1/2A clinical study to evaluate the safety, tolerability and efficacy of single and repeated doses of AUP1602-C as topical treatment of diabetic foot ulcers
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Study of BMS-354825 in Children and Adolescents With Relapsed or Refractory Leukemia : Phase I study of Src/Abl tyrosine kinase inhibitor dasatinib [BMS-354825] in children and adolescents with relapsed or refractory leukemia, Protocol ITCC 005.Revised Protocol 06, incorporating Protocol Amendment 07 and Administrative Letters 03 and 04 - Protocol ITCC 005
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Study of WVE-210201 in Patients Previously Enrolled in WVE-DMDX51-001 : A Multicenter, Open-Label Extension Study of WVE-210201 in Patients Previously Enrolled in WVE-DMDX51-001
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[2308]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1
Filter aufheben
Sprache: Englisch
Medienart
23.080
Aufsätze
23.080
E-Artikel
23.080
E-Ressourcen
Zeitschriftentitel
23.080
WHO International Clinical Trials Registry Plat...
Thema
23.080
610
Phase: Phase 1
20.968
Study Type: Interventional
8.346
Recruitment Status: Not yet recruiting
5.842
Recruitment Status: Completed
3.240
Recruitment Status: Authorised-recruitment may ...
3.132
Recruitment Status: Recruiting
1.448
Study Type: Observational
1.114
Recruitment Status: Complete: follow-up complete
220
Medical Condition: ;Not Applicable
194
Recruitment Status: Active, not recruiting
182
Recruitment Status: Complete: follow-up continuing
176
Study Type: BA/BE
134
Recruitment Status: Closed to Recruitment of Pa...
124
Study Type: Relative factors research
120
Recruitment Status: Stopped early
92
Medical Condition: ;Diseases of the circulatory...
90
Study Type: Diagnostic test
82
Recruitment Status: Withdrawn
78
Medical Condition: ;Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
15.574
2020-
7.506
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Englisch
Haven't found what you're looking for?
Wird geladen...